Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))

H Woopen; J Sehouli; A Davis; Y C Lee; P A Cohen; A Ferrero; N Gleeson; A Jhingran; Y Kajimoto; J Mayadev; M P Barretina-Ginesta; S Sundar; N Suzuki; E van Dorst; F Joly

doi:10.1016/j.ctrv.2022.102431

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))

H Woopen
, J Sehouli
, A Davis
, Y C Lee
, P A Cohen
, A Ferrero
, N Gleeson
, A Jhingran
, Y Kajimoto
, J Mayadev
, M P Barretina-Ginesta
, S Sundar
, N Suzuki
, E van Dorst
, F Joly

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

The publisher regrets that the survivorship care plan (Fig. 1) of the above article was incomplete. The complete version of the proposed survivorship care plan is now embedded as supplementary material in the article in a printable format. In addition, the author regrets that the details for affiliation “a” were incomplete. The correct affiliation is as listed above. The publisher and author would like to apologise for any inconvenience caused.

Original language	English
Article number	102431
Journal	Cancer Treatment Reviews
Volume	109
DOIs	https://doi.org/10.1016/j.ctrv.2022.102431
Publication status	Published - Sept 2022

Access to Document

10.1016/j.ctrv.2022.102431

1-s2.0-S0305737222001001-mainFinal published version, 254 KBLicence: Taverne

Fingerprint

Dive into the research topics of 'Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))'. Together they form a unique fingerprint.

Cite this

Woopen, H., Sehouli, J., Davis, A., Lee, Y. C., Cohen, P. A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M. P., Sundar, S., Suzuki, N., van Dorst, E., & Joly, F. (2022). Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396)). Cancer Treatment Reviews, 109, Article 102431. https://doi.org/10.1016/j.ctrv.2022.102431

Woopen, H ; Sehouli, J ; Davis, A et al. / Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer : A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396)). In: Cancer Treatment Reviews. 2022 ; Vol. 109.

@article{32ab79f048084999981068e5c2ac7d20,

title = "Erratum to {"}GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))",

abstract = "The publisher regrets that the survivorship care plan (Fig. 1) of the above article was incomplete. The complete version of the proposed survivorship care plan is now embedded as supplementary material in the article in a printable format. In addition, the author regrets that the details for affiliation “a” were incomplete. The correct affiliation is as listed above. The publisher and author would like to apologise for any inconvenience caused.",

author = "H Woopen and J Sehouli and A Davis and Lee, \{Y C\} and Cohen, \{P A\} and A Ferrero and N Gleeson and A Jhingran and Y Kajimoto and J Mayadev and Barretina-Ginesta, \{M P\} and S Sundar and N Suzuki and \{van Dorst\}, E and F Joly",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2022",

month = sep,

doi = "10.1016/j.ctrv.2022.102431",

language = "English",

volume = "109",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

}

Woopen, H, Sehouli, J, Davis, A, Lee, YC, Cohen, PA, Ferrero, A, Gleeson, N, Jhingran, A, Kajimoto, Y, Mayadev, J, Barretina-Ginesta, MP, Sundar, S, Suzuki, N, van Dorst, E & Joly, F 2022, 'Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))', Cancer Treatment Reviews, vol. 109, 102431. https://doi.org/10.1016/j.ctrv.2022.102431

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396)). / Woopen, H; Sehouli, J; Davis, A et al.
In: Cancer Treatment Reviews, Vol. 109, 102431, 09.2022.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer

T2 - A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))

AU - Woopen, H

AU - Sehouli, J

AU - Davis, A

AU - Lee, Y C

AU - Cohen, P A

AU - Ferrero, A

AU - Gleeson, N

AU - Jhingran, A

AU - Kajimoto, Y

AU - Mayadev, J

AU - Barretina-Ginesta, M P

AU - Sundar, S

AU - Suzuki, N

AU - van Dorst, E

AU - Joly, F

PY - 2022/9

Y1 - 2022/9

N2 - The publisher regrets that the survivorship care plan (Fig. 1) of the above article was incomplete. The complete version of the proposed survivorship care plan is now embedded as supplementary material in the article in a printable format. In addition, the author regrets that the details for affiliation “a” were incomplete. The correct affiliation is as listed above. The publisher and author would like to apologise for any inconvenience caused.

AB - The publisher regrets that the survivorship care plan (Fig. 1) of the above article was incomplete. The complete version of the proposed survivorship care plan is now embedded as supplementary material in the article in a printable format. In addition, the author regrets that the details for affiliation “a” were incomplete. The correct affiliation is as listed above. The publisher and author would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85134575682

U2 - 10.1016/j.ctrv.2022.102431

DO - 10.1016/j.ctrv.2022.102431

M3 - Comment/Letter to the editor

C2 - 35803179

SN - 0305-7372

VL - 109

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

M1 - 102431

ER -

Woopen H, Sehouli J, Davis A, Lee YC, Cohen PA, Ferrero A et al. Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396)). Cancer Treatment Reviews. 2022 Sept;109:102431. doi: 10.1016/j.ctrv.2022.102431

Abstract

Access to Document

Other files and links

Fingerprint

Cite this